OSM has also been shown to promote secretion of IL-6 in ERα- cells and not in ERα+ cells, further suggesting that OSM plays unique roles in ERα+ versus ERα- breast cancer (104, 106). This evidence concerns the gene ESR1 and breast carcinoma.